Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 11.68
+0.03 (0.26%)
At close: May 13, 2025, 2:57 PM CST
SHE:301301 Revenue
Yili Chuanning Biotechnology had revenue of 1.30B CNY in the quarter ending March 31, 2025, a decrease of -14.85%. This brings the company's revenue in the last twelve months to 5.53B, up 8.97% year-over-year. In the year 2024, Yili Chuanning Biotechnology had annual revenue of 5.76B with 19.38% growth.
Revenue (ttm)
5.53B
Revenue Growth
+8.97%
P/S Ratio
4.69
Revenue / Employee
1.74M
Employees
3,184
Market Cap
25.95B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |